TrialJournal of thrombosis and thrombolysis2020

β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease.

Ignatios Ikonomidis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.